The FDA recently announced its plan to phase out the animal testing requirement for monoclonal antibodies (mAbs) and other drugs, instead opting to use human-relevant new approach methodologies (NAMs) ...

South Africa’s Black woman-founded S.MAB Group appoints new CEO, keeping leadership in women’s hands. South Africa’s pioneering Black woman-founded S.MAB Group has appointed a new CEO, continuing its ...

SERB Pharmaceuticals will acquire Y-mAbs Therapeutics, focusing on pediatric oncology and antibody-based cancer treatments, including Danyelza for high-risk neuroblastoma. The acquisition deal values ...

Y-mAbs Therapeutics (NASDAQ:YMAB) is set to go private after SERB Pharmaceuticals announced on Tuesday that it would buy the cancer drug developer for an estimated $412M in equity value. The stock ...

(RTTNews) - SERB Pharmaceuticals (SERB), and Y-mAbs Therapeutics, Inc. (YMAB) have entered into a definitive merger agreement under which SERB will acquire Y-mAbs, including its lead commercial ...

Investing.com -- Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) stock surged 103% following the announcement that SERB Pharmaceuticals will acquire the company in an all-cash transaction valued at ...

After Y-mAbs Therapeutics won its first FDA approval more than four years ago, the company has faced numerous hurdles on its quest to become an oncology powerhouse. Now, the drugmaker is moving to ...

WEST CONSHOHOCKEN, Pa. and PRINCETON, N.J., Aug. 05, 2025 (GLOBE NEWSWIRE) -- SERB Pharmaceuticals (“SERB”), a global specialty pharmaceutical company focused on medicines for rare diseases and ...

The man who played a vital role in the establishment of Cork MABS (Money Advice and Budgeting Service) has been announced as the Cork Person of the Month for May. Patrick Coughlan retired as Manager ...

Innovative bioprocessing technologies are needed to make monoclonal antibody (mAb) production cheaper, according to new research, which suggests lowering the cost of goods (COGs) for mAb-based ...

Atlantic Technological University (ATU) and the Money Advice and Budgeting Service (MABS) have come together to address student financial well-being. The newly developed Financial Readiness for Life ...

Y-mAbs Therapeutics is parting ways with its chief commercial officer and putting a new hire in charge of the cancer drug Danyelza. The biotech made the changes, which include “a small adjustment” to ...